Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|May 18, 2007
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCATGeorgios Koukos, Angeliki Chroni, Adelina Duka, et al.
Biochemistry|September 5, 2015
Influence of Isoforms and Carboxyl-Terminal Truncations on the Capacity of Apolipoprotein E To Associate with and Activate Phospholipid Transfer ProteinIoannis Dafnis, Jari Metso, Vassilis I Zannis, et al.
Biochemistry|May 8, 2015
The Effect of Natural LCAT Mutations on the Biogenesis of HDLPanagiotis Fotakis, Jan Albert Kuivenhoven, Eugene Dafnis, et al.
Biochemistry|October 26, 2005
Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiencyAngeliki Chroni, Adelina Duka, Horng-Yuan Kan, et al.
Biochemistry|March 9, 2005
Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient miceAngeliki Chroni, Horng-Yuan Kan, Adelina Shkodrani, et al.
The Journal of Biological Chemistry|April 26, 2007
A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in miceKonstantinos Drosatos, Despina Sanoudou, Kyriakos E Kypreos, et al.
Journal of Lipid Research|February 4, 2010
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolismDimitrios Iliopoulos, Konstantinos Drosatos, Yaeko Hiyama, et al.
Clinical Chemistry and Laboratory Medicine|May 16, 2003
Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapyVassilis I Zannis, Tong Liu, Markella Zanni, et al.
The Biochemical Journal|February 15, 2003
Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoidsDimitris Kardassis, Anastasia Roussou, Paraskevi Papakosta, et al.
Journal of Lipid Research|April 30, 2014
apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDLPanagiotis Fotakis, Alexander Vezeridis, Ioannis Dafnis, et al.
Pageof 7